APA (7th ed.) Citation

MJ, C., M, G., T, D., H, W., J, S., M, B., . . . V, W. (2025). Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study. European urology oncology, 8(3), 663. https://doi.org/10.1016/j.euo.2024.06.010

Chicago Style (17th ed.) Citation

MJ, Connor, et al. "Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study." European Urology Oncology 8, no. 3 (2025): 663. https://doi.org/10.1016/j.euo.2024.06.010.

MLA (9th ed.) Citation

MJ, Connor, et al. "Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study." European Urology Oncology, vol. 8, no. 3, 2025, p. 663, https://doi.org/10.1016/j.euo.2024.06.010.